ASI Trademark

Trademark Overview


On Thursday, March 21, 2024, a trademark application was filed for ASI with the United States Patent and Trademark Office. The USPTO has given the ASI trademark a serial number of 98460090. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, September 29, 2024. This trademark is owned by Seragon Pharmaceuticals Inc.. The ASI trademark is filed in the Medical Instrument Products category with the following description:

Kits for use in epigenetic testing for scientific analysis and informational reports comprising a saliva collection tube, caps for tube, and mailing packaging for use in testing of humans
asi

General Information


Serial Number98460090
Word MarkASI
Filing DateThursday, March 21, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, September 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesKits for use in epigenetic testing for scientific analysis and informational reports comprising a saliva collection tube, caps for tube, and mailing packaging for use in testing of humans

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 21, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeragon Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events


Event DateEvent Description
Thursday, March 21, 2024NEW APPLICATION ENTERED
Thursday, August 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 29, 2024NON-FINAL ACTION WRITTEN
Sunday, September 29, 2024ASSIGNED TO EXAMINER
Sunday, September 29, 2024NON-FINAL ACTION E-MAILED